Fabrication, implantation, elution, and retrieval of a steroid-loaded polycaprolactone subretinal implant

Journal of Biomedical Materials Research - Part A

Volumn 73, Issue 4, 2005, Pages 437-444

  Beeley, Nathan R F ^a   Rossi, Juliana V ^a   Mello Filho, Paulo A A ^a   Mahmoud, Mahmoud I ^a   Fujii, Gildo Y ^a   De Juan Jr , Eugene ^a   Varner, Signe E ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Angiogenesis; Biocompatibility; Biodegradation; Drug delivery; Ocular; Polycaprolactone; Retina; Sustained release; Triamcinolone

Indexed keywords

BIODEGRADATION; CELLS; CONTROLLED DRUG DELIVERY; DISEASES; HISTOLOGY; MICROSTRUCTURE; OPHTHALMOLOGY; POLYMERS;

INFLAMMATORY RESPONSE; POLYCAPROLACTONE; RETINAL DISEASES; SUBRETINAL DRUG DELIVERY;

IMPLANTS (SURGICAL);

BALANCED SALT SOLUTION; CORTICOSTEROID; POLYCAPROLACTONE; POLYMER; SERUM ALBUMIN; SOLVENT; TRIAMCINOLONE ACETONIDE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; CELL STRUCTURE; DRUG DELIVERY SYSTEM; ELUTION; ENCAPSULATION; EYE PHOTOGRAPHY; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; IMPLANT; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; RABBIT; RETINA; SUSTAINED RELEASE PREPARATION;

ABSORBABLE IMPLANTS; ANGIOGRAPHY; ANIMALS; AQUEOUS HUMOR; BIOCOMPATIBLE MATERIALS; CELL PROLIFERATION; CHOROID; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; NEOVASCULARIZATION, PATHOLOGIC; POLYESTERS; POLYMERS; PROSTHESES AND IMPLANTS; PROSTHESIS IMPLANTATION; RABBITS; RETINA; SERUM ALBUMIN, BOVINE; STEROIDS; TIME FACTORS; TRIAMCINOLONE;

EID: 20344367783     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.30294     Document Type: Article

References (15)

1. Park CH, Jaffe GJ, Fekrat S. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion Am J Ophthalmol 2003;136:419-425.
2. Bourges JL, Gautier SE, Delie F, Bejjani RA, Jeanny JC, Gurny R, BenEzra D, Behar-Cohen FF. Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles. Invest Ophthalmol Vis Sci 2003;44:3562-3569.
3. Jaffe GJ, Yang CS, Wang XC, Cousins SW, Gallemore RP, Ashton P. Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis. Ophthalmology 1998;105:46-56.
4. Gilger BC, Malok E, Stewart T, Ashton P, Smith T, Jaffe GJ, Allen JB. Long-term effect on the equine eye of an intravitreal device used for sustained release of cyclosporine A. Vet Ophthalmol 2000;3:105-110.
5. Gillies MC, Simpson JM, Billson FA, Luo W, Penfold P, Chua W, Mitchell P, Zhu M, Hunyor AB. Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. Arch Ophthalmol 2004;122:336-340.
6. Jaissle GB, Szurman P, Bartz-Schmidt KU. Ocular side effects and complications of intravitreal triamcinolone acetonide injection. Ophthalmologe 2004;101:121-128.
7. Truhan AP, Ahmed AR. Corticosteroids: a review with emphasis on complications of prolonged systemic therapy. Ann Allergy 1989;62:375-391.
8. Nesbitt LT Jr. Minimizing complications from systemic glucocorticoid use. Dermatol Clin 1995;13:925-939.
9. Lester RS, Knowles SR, Shear NH. The risks of systemic corticosteroid use. Dermatol Clin 1998;16:277-288.
10. Lakhanpal RR, Yanai D, Weiland JD, Fujii GY, Caffey S, Greenberg RJ, de Juan E Jr, Humayun MS. Advances in the development of visual prostheses. Curr Opin Ophthalmol 2003;14:122-127.
11. Kimura H, Sakamoto T, Hinton DR, Spee C, Ogura Y, Tabata Y, Ikada Y, Ryan SJ. A new model of subretinal neovascularization in the rabbit. Invest Ophthalmol Vis Sci 1995;36:2110-2119.
12. Ishibashi T, Miki K, Sorgente N, Patterson R, Ryan SJ. Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate. Arch Ophthalmol 1985;103:708-711.
13. Ciulla TA, Criswell MH, Danis RP, Hill TE. Intravitreal triamcinolone inhibits choroidal neovascularization in a laser-treated rat model. Arch Ophthalmol 2001;119:399-404.
14. Pitt CG. Poly ε caprolactone and its copolymers. In: Chassin M, Langer R, editors. Biodegradable polymers as drug delivery systems. New York: Dekker; 1990. p 71-119.
15. Coombes AG, Rizzi SC, Williamson M, Barralet JE, Downes S, Wallace WA. Precipitation casting of polycaprolactone for applications in tissue engineering and drug delivery. Biomaterials 2004;25:315-325